Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Canadian Methotrexate and Etanercept Outcome Study: An Open Label Randomized Trial of Etanercept and Methotrexate Versus Etanercept Alone in the Treatment of Rheumatoid Arthritis (CAMEO)

NCT00654368 is registered in ClinicalTrials.gov with Amgen as lead sponsor.

NCT NCT00654368
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00654368 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Canadian Methotrexate and Etanercept Outcome Study: An Open Label Randomized Trial of Etanercept and Methotrexate Versus Etanercept Alone in the Treatment of Rheumatoid Arthritis (CAMEO)
Lead sponsor
Amgen
Phase
Phase 4
Overall status
Completed
Start date
June 30, 2008
Completion date
February 28, 2013
Enrollment
258 (actual)
Sites
28

Conditions

As the registry lists them; a condition with its own page is linked.

rheumatoid arthritis